ArticleInfluenza and other respiratory viruses2019
Modelling the population effectiveness of the national seasonal influenza vaccination programme in Scotland: The impact of targeting all individuals aged 65 years and over.
Article in Influenza and other respiratory viruses, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Exploring the impact of changing government policy on vaccination eligibility for 50-64 year olds: A qualitative thematic analysis in England and Scotland.Human vaccines & immunotherapeutics · 2025Article
- Is COVID-19 a Real Incentive for Flu Vaccination? Let the Numbers Speak for Themselves.Vaccines · 2021Article
- Potency of Lianhua Qingwen granule combined with paramivir sodium chloride injection in treating influenza and level changes of serum inflammatory factors.American journal of translational research · 2021Article
- Strategies to Increase Flu Vaccination Coverage among Healthcare Workers: A 4 Years Study in a Large Italian Teaching Hospital.Vaccines · 2020Article
- Modelling the population effectiveness of the national seasonal influenza vaccination programme in Scotland: The impact of targeting all individuals aged 65 years and over.Influenza and other respiratory viruses · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFor the last 17 years, the UK has employed a routine influenza vaccination programme with the aim of reducing the spread of seasonal influenza. In mid-2000, the programme moved from a purely risk-based approach to a risk and age group-targeted approach with all those aged 65+ years being included. To date, there has been no assessment of the population effectiveness of this age-targeted policy in Scotland.
objectivesStatistical modelling techniques were used to determine what impact the routine vaccination of those aged 65+ years has had on influenza-related morbidity and mortality in Scotland.
methodsTwo Poisson regression models were developed using weekly counts of all-cause mortality, cause-specific mortality and emergency hospitalisations for the period 1981-2012, one using week-in-year and the other using temperature to capture the seasonal variability in mortality/hospitalisations. These models were used to determine the number of excess deaths/hospitalisations associated with the introduction of the local risk and age-based vaccination programme in 2000.
resultsRoutinely vaccinating those aged 65+ years is associated with a reduction in excess all-cause mortality, cardiovascular and COPD-related mortality and COPD-related hospitalisations. Our analysis suggests that using the week-in-year model, on average, 732 (95% CI 66-1398) deaths from all causes, 248 (95% CI 10-486) cardiovascular-related deaths, 123 (95% CI 28-218) COPD-related deaths and 425 (95% CI 258-592) COPD-related hospitalisations have been prevented each flu season among the those aged 65+. Similar results were found using the temperature model. There was no evidence to suggest that the change in policy was associated with reductions in influenza/pneumonia-related mortality or influenza/cardiovascular-related hospitalisations.
conclusionsRoutinely vaccinating those aged 65+ years appears to have reduced influenza-related morbidity and mortality in Scotland. With the childhood vaccination programme well underway, these data provide an importance benchmark which can be used to accurately assess the impact of this new seasonal influenza vaccination programme.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.